AGGRESSIVE PERIODONTITIS

Comprehensive Postgraduate Theory Examination Notes

Sources used throughout:

• Carranza 10th ed. = Carranza's Clinical Periodontology, 10th Edition (Newman, Michael G., Elsevier, 2006-07), Chapter 33
• Newman-Carranza 14th ed. = Newman and Carranza's Clinical Periodontology and Implantology, 14th Edition, Chapters 11, 39
• Lang-Lindhe 6th ed. = Clinical Periodontology and Implant Dentistry, 6th Edition (Lang NP, Lindhe J, eds., Wiley-Blackwell, 2015), Chapter 21
• S. Reddy Essentials = Essentials of Clinical Periodontology and Periodontics, Chapter 26

---

1. DEFINITION AND INTRODUCTION

• Aggressive periodontitis is characterized by rapid loss of attachment and bone loss occurring in an otherwise clinically healthy patient, with the amount of microbial deposits inconsistent with disease severity and familial aggregation of diseased individuals. [S. Reddy Essentials, Ch. 26]
• "Aggressive periodontitis generally affects systemically healthy individuals less than 30 years old, although patients may be older. It may be universally distinguished from chronic periodontitis by the age of onset, the rapid rate of disease progression, the nature and composition of the associated subgingival microflora, alterations in the host's immune response, and a familial aggregation of diseased individuals." [Carranza 10th ed., Ch. 33]
• AgP comprises "a group of rare, often severe, rapidly progressive forms of periodontitis, often characterized by an early age of clinical manifestation and a distinctive tendency for cases to aggregate in families." [Lang-Lindhe 6th ed., Ch. 21]
• A strong racial influence is observed in the United States; the disease is more prevalent among African Americans. [Carranza 10th ed., Ch. 33]

---

2. RECENT TERMINOLOGY CHANGES / HISTORICAL EVOLUTION OF NOMENCLATURE

Table 1: Nomenclature Evolution of Aggressive Periodontitis

Key Terminology Change (Examiner Keyword):

• LJP (Localized Juvenile Periodontitis) → LAP (Localized Aggressive Periodontitis)
• GJP (Generalized Juvenile Periodontitis) + RPP (Rapidly Progressive Periodontitis) → GAP (Generalized Aggressive Periodontitis)
• EOP (Early-Onset Periodontitis) → Aggressive Periodontitis (AgP)

Note on 2017 Classification: The 14th ed. (Newman-Carranza) reflects the move toward staging and grading; "aggressive periodontitis" as a discrete category was proposed to be subsumed under the 2017 World Workshop framework, but the 1999 classification terminology (LAP/GAP) remains the basis for all clinical description and examination purposes.

---

3. CLASSIFICATION

1999 International Classification Workshop (Lang et al.) - Primary Features of AgP:

1. Non-contributory medical history (otherwise clinically healthy patient)
2. Rapid attachment loss and bone destruction
3. Familial aggregation of cases

Secondary Features (generally but not universally associated):

1. Amounts of microbial deposits inconsistent with severity of periodontal tissue destruction
2. Elevated proportions of Aggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans)
3. Phagocyte abnormalities
4. Hyper-responsive macrophage/monocyte phenotype including elevated levels of PGE2 and IL-1β
5. Self-limiting progression in some cases

Flowchart 1: Classification of Aggressive Periodontitis (1999 AAP)

AGGRESSIVE PERIODONTITIS
         |
         ├──────────────────────────────────────────┐
         ↓                                          ↓
LOCALIZED (LAP)                          GENERALIZED (GAP)
[formerly LJP]                   [formerly GJP + RPP]
         |                                          |
Circumpubertal onset               Usually < 30 years of age
(around puberty)                   (older patients may be affected)
         |                                          |
Localized first molar/             Generalized interproximal
incisor presentation               attachment loss affecting at
                                   least 3 permanent teeth other
                                   than first molars and incisors
         |                                          |
Interproximal attachment           Episodic progression
loss on ≥ 2 permanent              (periods of destruction
teeth, one being a                 followed by quiescence)
first molar; ≤ 2 other
teeth affected                    
         |                                          |
Robust serum antibody              Poor serum antibody
response to infecting agents       response to infecting agents

---

4. LOCALIZED AGGRESSIVE PERIODONTITIS (LAP)

4A. CLINICAL CHARACTERISTICS

• LAP usually has an age of onset at about puberty (circumpubertal). [Carranza 10th ed., Ch. 33]
• "A striking feature is the lack of clinical inflammation despite the presence of deep periodontal pockets." [S. Reddy Essentials, Ch. 26; Carranza 10th ed., Ch. 33]
• The amount of plaque is minimal, "forming a thin biofilm on the teeth and rarely mineralizes to form calculus." [Carranza 10th ed., Ch. 33]
• The plaque that is present contains elevated levels of A. actinomycetemcomitans, and in some patients, Porphyromonas gingivalis. [Carranza 10th ed., Ch. 33]
• Evidence suggests the rate of bone loss is about three to four times faster than in chronic periodontitis. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]

1. Distolabial migration of the maxillary incisors with concomitant diastema formation [most classic feature]
2. Increasing mobility of the maxillary and mandibular incisors and first molars
3. Root surface sensitivity to thermal and tactile stimuli (from denuded root surfaces)
4. Deep, dull, radiating pain during mastication, probably caused by irritation of supporting structures by mobile teeth and impacted food
5. Periodontal abscess formation may occur at this stage
6. Regional lymph node enlargement may occur

• "Not all cases of LAP progress to the degree just described. In some patients the progression of attachment loss and bone loss may be self-arresting." [Carranza 10th ed., Ch. 33]

Bursting / Rate of Progression:

• "Rate of progression is three to four times more than chronic periodontitis" explaining burst, random burst and multiple asynchronous patterns of disease progression. [S. Reddy Essentials, Ch. 26]

---

4B. DIAGNOSTIC FEATURES OF LAP (Examiner Keywords)

---

4C. RADIOGRAPHIC FINDINGS IN LAP

• "Vertical loss of alveolar bone around the first molars and incisors, beginning around puberty in otherwise healthy teenagers, is a classic diagnostic sign of LAP." [Carranza 10th ed., Ch. 33]
• Classic radiographic pattern: "arc-shaped loss of alveolar bone extending from the distal surface of the second premolar to the mesial surface of the second molar." [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
• "Frequently, bilaterally symmetrical patterns of bone loss occur, called 'mirror image pattern'." [S. Reddy Essentials, Ch. 26]
• Bone defects are usually wider than those seen with chronic periodontitis. [Carranza 10th ed., Ch. 33]
• Bone loss may occur initially in the maxillary and mandibular incisor and/or first molar areas, usually bilaterally, resulting in vertical, arclike destructive patterns. [Carranza 10th ed., Ch. 36]
• Loss of alveolar bone may become generalized as disease progresses but remains less pronounced in the premolar areas. [Carranza 10th ed., Ch. 36]
• "Early furcation involvement suggested by fuzziness in the bifurcation of the mandibular first molar, particularly when associated with bone loss on the roots." [Carranza 10th ed., Ch. 36]

---

4D. PREVALENCE AND DISTRIBUTION (LAP)

---

5. GENERALIZED AGGRESSIVE PERIODONTITIS (GAP)

5A. CLINICAL CHARACTERISTICS

• GAP "usually affects individuals under age 30, but older patients also may be affected." [Carranza 10th ed., Ch. 33]
• "In contrast to LAP, evidence suggests that individuals affected with GAP produce a poor antibody response to the pathogens present." [Carranza 10th ed., Ch. 33]
• Clinically characterized by "generalized interproximal attachment loss affecting at least three permanent teeth other than first molars and incisors." [Carranza 10th ed., Ch. 33]
• Destruction occurs episodically, with "periods of advanced destruction followed by stages of quiescence of variable length (weeks to months or years)." [Carranza 10th ed., Ch. 33]
• As in LAP, patients often have small amounts of bacterial plaque inconsistent with the amount of periodontal destruction. [Carranza 10th ed., Ch. 33]
• Qualitatively: P. gingivalis, A. actinomycetemcomitans, and Tannerella forsythia (formerly Bacteroides forsythus) frequently detected. [Carranza 10th ed., Ch. 33]

1. Severe, acutely inflamed tissue: "often proliferating, ulcerated, and fiery red. Bleeding may occur spontaneously or with slight stimulation. Suppuration may be an important feature." — Believed to occur in the destructive stage [Carranza 10th ed., Ch. 33]
2. Pink, free of inflammation, occasionally with stippling — despite apparently mild appearance, deep pockets can be demonstrated by probing [Carranza 10th ed., Ch. 33]

• Radiographs often show bone loss that has progressed since the radiographic examination. [Carranza 10th ed., Ch. 33]
• "Page et al. described sites in GAP patients that demonstrated osseous destruction of 25% to 60% during a 9-week period. Despite this extreme loss, other sites in the same patient showed no bone loss." [Carranza 10th ed., Ch. 33]
• As seen with LAP, cases of GAP "may be arrested spontaneously or after therapy, whereas others may continue to progress inexorably to tooth loss despite intervention with conventional treatment." [Carranza 10th ed., Ch. 33]

5B. PREVALENCE (GAP)

• U.S. national survey (age 14-17): 0.13% had GAP [Carranza 10th ed., Ch. 33]
• Sri Lanka untreated periodontal disease study (Löe et al.): 8% of population had rapid progression characterized by yearly loss of attachment of 0.1 to 1.0 mm [Carranza 10th ed., Ch. 33]
• Blacks were at much higher risk than whites; male teenagers more likely to have GAP than female adolescents [Carranza 10th ed., Ch. 33]

---

6. COMPARISON TABLE: LAP vs. GAP

Table 2: Differences Between LAP and GAP

---

7. ETIOLOGY AND PATHOGENESIS

Flowchart 2: Pathogenesis of Aggressive Periodontitis

PATHOGENESIS OF AGGRESSIVE PERIODONTITIS
                    |
     _______________↓_______________
     |                             |
MICROBIAL FACTORS           HOST FACTORS
(Primary Pathogen:          (Genetic predisposition +
A. actinomycetemcomitans)    Immune defects)
     |                             |
     ↓                             ↓
Virulence factors:          PMN/Monocyte dysfunction:
• Leukotoxin                • Impaired chemotaxis
• Endotoxin/LPS             • Decreased phagocytosis
• Bacteriocin               • Deficiency of GP110
• Collagenase               • Hyper-responsive monocytes
• Chemotaxis inhibitors       → elevated PGE2, IL-1β
• Epitheliotoxin
     |                             |
     |___________↓_________________|
                 |
     Interaction → Tissue breakdown
                 |
     ↓           ↓           ↓
Collagen     Bone        Attachment
destruction  resorption  loss

---

7A. MICROBIOLOGICAL FACTORS

1. Found in high frequency (~90%) in lesions characteristic of LAP
2. Sites with evidence of disease progression often show elevated levels of Aa
3. Many LAP patients have significantly elevated serum antibody titers to Aa
4. Correlation between reduction in subgingival load of Aa during treatment and successful clinical response
5. Aa produces a number of virulence factors that may contribute to the disease process

Table 3: Virulence Factors of Aggregatibacter actinomycetemcomitans

• "Electron microscopy studies of LAP have revealed bacterial invasion of connective tissue that reaches the bone surface. The invading flora has been described as morphologically mixed but composed mainly of gram-negative bacteria, including cocci, rods, filaments, and spirochetes." [Carranza 10th ed., Ch. 33]

• Several studies provided evidence for transmission of A. actinomycetemcomitans between humans, e.g., from parent to child or between spouses. [Lang-Lindhe 6th ed., Ch. 21]
• "If A. actinomycetemcomitans is a real exogenous pathogen for LAP or AgP in general, avoidance of exposure to the organism becomes a relevant issue in prevention." [Lang-Lindhe 6th ed., Ch. 21]

---

7B. HOST FACTORS - IMMUNOLOGICAL DEFECTS

• "Approximately 75% of patients with LAP have dysfunctional neutrophils," seen as decreased chemotactic response to several chemotactic agents including:
  • Complement component C5a
  • N-formyl-methionyl-leucyl-phenylalanine (FMLP)
  • Leukotriene B4
• The defect is also associated with a 40% deficiency in glycoprotein GP110 on the neutrophil surface. [S. Reddy Essentials, Ch. 26]

• "Patients with LAP demonstrate a strong antibody response to A. actinomycetemcomitans, which explains the limitation of the infection."
• In LAP, the dominant serum antibody is IgG2 type, which is specific to antigens of A. actinomycetemcomitans. [S. Reddy Essentials, Ch. 26]
• "In generalized form, host response is often characterized by defects in either neutrophils or monocytes." [S. Reddy Essentials, Ch. 26]

• Local inflammatory responses characterized by "high levels of PGE2, IL-1α, and IL-1β in both crevicular fluid and tissue." [Lang-Lindhe 6th ed., Ch. 21]
• "Peripheral blood mononuclear cells from AgP patients have been reported to exhibit a reduced autologous mixed lymphocyte reaction, as well as a higher than normal response to B-cell mitogens." [Lang-Lindhe 6th ed., Ch. 21]

• Intense recruitment of PMNs within the tissues and into the periodontal pocket
• B cells and antibody-producing plasma cells represent a significant component
• Plasma cells predominantly IgG-producing (lower proportion IgA)
• Local IgG4-producing cells particularly elevated
• Depressed T-helper-to-T-suppressor ratio as compared to both healthy gingiva and peripheral blood [Lang-Lindhe 6th ed., Ch. 21]

---

7C. GENETIC FACTORS

• "Some of the immunologic defects seen in aggressive periodontitis may have a genetic basis; familial clustering of neutrophil abnormalities may be seen." [S. Reddy Essentials, Ch. 26]
• Evidence from formal genetic studies supports "the existence of a gene of major effect" in AgP. [Lang-Lindhe 6th ed., Ch. 21]
• Genetic predisposition is determined by a single gene of major effect, inherited as an autosomal dominant trait. [Lang-Lindhe 6th ed., Fig. 21-9]
• Modifying genes may control immune responses that determine the clinical extent and severity of periodontal destruction (e.g., allele controlling IgG2 levels inherited as a co-dominant trait). [Lang-Lindhe 6th ed., Ch. 21]
• High IgG2 titers limit disease extension (LAP); intermediate and low IgG2 titers are less effective (GAP). [Lang-Lindhe 6th ed., Ch. 21]
• Allelic variations in the Fc receptor for IgG2 (FcγRIIa): PMNs expressing the R131 allotype (arginine instead of histidine at amino acid 131) show decreased phagocytosis of A. actinomycetemcomitans. [Lang-Lindhe 6th ed., Ch. 21]

Table 4: Genetic and Inherited Disorders Associated with Aggressive Periodontitis

Candidate Genes Related to Risk of Aggressive Periodontitis:

• Interleukin (IL)-1 gene cluster (IL-1A, IL-1B, IL-1 receptor antagonist), IL-4, IL-6, IL-10
• TNF-alpha
• Leukocyte receptors for the constant (Fc) part of immunoglobulin (FcγR)
• Vitamin D receptor
• Pattern recognition receptor genes (TLRs, CD-14)
• Matrix metalloproteinase (MMP)-1

---

7D. ENVIRONMENTAL FACTORS

• "Cigarette smoking was shown to be a risk factor for patients with generalized forms of AgP (Schenkein et al. 1995)."
• "Smokers with GAP had more affected teeth and greater mean levels of attachment loss than patients with GAP who did not smoke."

• Mechanism: "IgG2 serum levels as well as antibody levels against A. actinomycetemcomitans are significantly depressed in subjects with GAP who smoke." [Lang-Lindhe 6th ed., Ch. 21]

---

7E. WHY DESTRUCTION IS LOCALIZED IN LAP - PATHOGENESIS OF LIMITATION

1. After initial colonization of first permanent teeth to erupt (first molars and incisors), Aa evades host defenses (via leukotoxin, endotoxin, collagenases, PMN chemotaxis-inhibiting factors). After initial attack, adequate immune defenses produce opsonic antibodies - "burnout phenomenon" - preventing colonization of other sites. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
2. Bacteria antagonistic to A. actinomycetemcomitans may colonize periodontal tissues and inhibit further colonization. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
3. A. actinomycetemcomitans may lose its leukotoxin-producing ability for unknown reasons. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
4. Localization of lesions could also be due to a defect in cementum formation (hypoplastic/aplastic cementum). [S. Reddy Essentials, Ch. 26]

---

7F. STAGES IN DEVELOPMENT OF DISEASE (Orban and Weinmann, 1942 - Historical)

• Stage 1: Involves the degeneration of principal fibers of the PDL
• Stage 2: [Degeneration progresses]
• Stage 3: [Advanced stage with pocket formation and bone loss]

---

8. CEMENTUM PATHOLOGY IN LAP

• Lindskog and Blomlöf documented cementum hypoplasia in teeth affected by juvenile periodontitis.
• Cementum defects may contribute to colonization by pathogens and to localization of disease.

---

9. DIAGNOSIS OF AGGRESSIVE PERIODONTITIS

Clinical Diagnosis (Tentative - Based on 4 Criteria):

1. Absence of significant systemic conditions
2. Rapid attachment loss and bone destruction
3. Familial aggregation of cases
4. Lack of consistency between clinically visible bacterial deposits and severity of periodontal breakdown

"The International Classification Workshop consensus indicated that not all listed primary and secondary features need to be present in order to assign a diagnosis of AgP and that the diagnosis may be based on clinical, radiographic, and historical data alone. It also indicated that laboratory testing, although helpful, may not be essential in making an AgP diagnosis." [Lang-Lindhe 6th ed., Ch. 21]

Differential Diagnosis: LAP vs. GAP

Microbiologic Diagnosis:

• Detection of A. actinomycetemcomitans by DNA probe, culture, or PCR
• Useful to guide antibiotic selection
• "Detection of patients infected with A. actinomycetemcomitans but producing low levels of specific antibodies may allow early identification of a high-risk group for GAP." [Lang-Lindhe 6th ed., Ch. 21]
• "Serum antibody titers (IgG2 in particular) and/or avidity to A. actinomycetemcomitans may be particularly useful in the differential diagnosis of GAP and LAP." [Lang-Lindhe 6th ed., Ch. 21]

Evaluation of Host Defenses:

• PMN functional assays: chemotaxis to C5a, FMLP, leukotriene B4
• Peripheral blood smear
• FcγRIIa allotype testing

Genetic Diagnosis:

• "Given the disproportionately high incidence of AgP in the families of affected individuals, evaluation of siblings of the proband and other family members is a requirement."
• Construction of a pedigree of the AgP trait
• Helps establish the need for monitoring clinically unaffected individuals

Screening:

• In younger subjects: measurement of the distance between the alveolar crest and the CEJ on bitewing radiographs
• "A distance of 2 mm between the CEJ and the alveolar crest, in the absence of local factors (caries, fillings, open contacts), argues for a suspected diagnosis of periodontitis." [Lang-Lindhe 6th ed., Ch. 21]
• In older adolescents and adults: periodontal probing is more appropriate than radiographs for screening

---

10. TREATMENT OF AGGRESSIVE PERIODONTITIS

Flowchart 3: Treatment Approach for Aggressive Periodontitis

TREATMENT OF AGGRESSIVE PERIODONTITIS
              |
              ↓
1. EARLY DIAGNOSIS (specialist - periodontist)
              |
              ↓
2. INITIAL/CAUSE-RELATED THERAPY
   • Oral hygiene instruction
   • Supragingival plaque control (< 25% sites with detectable plaque)
   • Scaling and root planing (SRP) - within 2 days ideally
              |
              ↓
3. ADJUNCTIVE SYSTEMIC ANTIBIOTIC THERAPY
   (concurrent with or immediately after SRP)
   First-line: Metronidazole 500mg TID + Amoxicillin 500mg TID × 7 days
   OR: Tetracycline HCl 250 mg QID × 14 days
   (See antibiotic table below)
              |
              ↓
4. SURGICAL PHASE (if indicated)
   • Modified Widman flap
   • Bone grafting (for osseous defects)
   • Root amputation/hemisection
   • Occlusal adjustment
              |
              ↓
5. MAINTENANCE PHASE
   • Frequent maintenance visits
   • Microbiological monitoring
   • Re-evaluation and retreatment if needed

---

Table 5: Antibiotic Therapy for Aggressive Periodontitis

1. A. actinomycetemcomitans elimination is central to successful therapy; recurrent lesions still harbor this organism. [Lang-Lindhe 6th ed., Ch. 21]
2. "Scaling and root planing alone could not predictably suppress A. actinomycetemcomitans below detection levels." [Lang-Lindhe 6th ed., Ch. 21]
3. "Systemic antibiotics should only be administered as an adjunct to mechanical debridement because in undisturbed subgingival plaque, the target organisms are effectively protected from the antibiotic agent due to the biofilm effect." [Lang-Lindhe 6th ed., Ch. 21]
4. "Systemic tetracycline (250 mg of tetracycline hydrochloride four times daily for at least 1 week) should be given in conjunction with local mechanical therapy." [Carranza 10th ed., Ch. 46]
5. If surgery is indicated, "systemic tetracycline should be prescribed and the patient instructed to begin taking the antibiotic approximately 1 hour before surgery." [Carranza 10th ed., Ch. 46]
6. "Chlorhexidine rinses should be prescribed and continued for several weeks to enhance plaque control and facilitate healing." [Carranza 10th ed., Ch. 46]
7. Current protocol (Guerrero et al. 2005 - validated in RCTs): (1) achievement of supragingival plaque control (<25% sites); (2) rigorous subgingival instrumentation with hand and ultrasonic instruments completed within 2 days; (3) metronidazole 500 mg TID + amoxicillin 500 mg TID × 7 days. [Lang-Lindhe 6th ed., Ch. 21]
8. "Early antibiotic administration [concurrent with SRP] showed benefit over later administration." [Lang-Lindhe 6th ed., Ch. 21]

• Extraction of involved teeth, especially first molars → uneventful healing; transplantation of developing third molars into extracted first molar sockets tried but with limited success
• Standard periodontal therapy: scaling, root planing, curettage, flap surgery with/without bone grafts, root amputation, hemisection, occlusal adjustment, strict plaque control — response unpredictable, frequent maintenance mandatory
• Genco's regimen: SRP + tetracycline 250 mg QID for 14 days every 8 weeks

• "Prognosis is no more considered as poor for patients with aggressive periodontitis." [S. Reddy Essentials, Ch. 26]
• "These patients often present with limited microbial deposits that seem inconsistent with the severity of tissue destruction. However, the deposits that are present often have elevated levels of A. actinomycetemcomitans." [Carranza 10th ed., Ch. 40 - Prognosis section]
• Successful treatment "considered to be dependent on early diagnosis, directing therapy towards elimination or suppression of the infecting microorganisms and providing an environment conducive to long-term maintenance." [Lang-Lindhe 6th ed., Ch. 21]

---

11. DIFFERENT VIEWPOINTS ACROSS REFERENCES

Table 6: Comparison of Different Viewpoints Across Uploaded References

---

12. HISTOPATHOLOGY / MICROSCOPIC FEATURES

• Gottlieb (1923) described: "loss of collagen fibers in the periodontal ligament (PDL) and their replacement by loose connective tissue and extensive bone resorption, resulting in a widened PDL space. The gingiva apparently was not involved." [Carranza 10th ed., Ch. 33]
• Electron microscopy: bacterial invasion of connective tissue reaching the bone surface; gram-negative organisms including cocci, rods, filaments, spirochetes. [Carranza 10th ed., Ch. 33]
• "B cells and antibody-producing plasma cells represent a significant component of the mononuclear cell-dominated connective tissue lesion." [Lang-Lindhe 6th ed., Ch. 21]
• "T cells: depressed T-helper-to-T-suppressor ratio as compared to both healthy gingiva and peripheral blood." [Lang-Lindhe 6th ed., Ch. 21]

---

13. BONE DESTRUCTION PATTERN

• "A vertical or angular pattern of alveolar bone destruction is found around the first molars in aggressive periodontitis." [Carranza 10th ed., Ch. 28]
• "The cause of the localized bone destruction in this type of periodontal disease is unknown." [Carranza 10th ed., Ch. 28]
• Bone defects are usually wider than seen in chronic periodontitis. [Carranza 10th ed., Ch. 33]

---

14. PROGNOSIS IN AGGRESSIVE PERIODONTITIS

• In aggressive periodontitis, prognosis is questionable (guarded) to poor in advanced cases.
• Prognosis depends on: (1) early detection; (2) patient compliance; (3) antibiotic adjuncts; (4) genetic susceptibility; (5) maintenance therapy adherence.
• "As seen with LAP, cases of GAP may be arrested spontaneously or after therapy, whereas others may continue to progress inexorably to tooth loss despite intervention with conventional treatment." [Carranza 10th ed., Ch. 33]
• "Prognosis is no more considered as poor for patients with aggressive periodontitis." [S. Reddy Essentials, Ch. 26]
• "Successful treatment...is considered to be dependent on early diagnosis, directing therapy towards elimination or suppression of the infecting microorganisms and providing an environment conducive to long-term maintenance. The differential element of treatment of AgP, however, relates to specific efforts to affect the composition and not only the quantity of the subgingival microbiota." [Lang-Lindhe 6th ed., Ch. 21]

---

15. RISK FACTORS SUMMARY

Table 7: Risk Factors for Aggressive Periodontitis

---

16. EXAMINER KEYWORDS SUMMARY BOX

The following bold keywords are high-frequency examination terms extracted verbatim from sources:

• "Localized first molar/incisor presentation"
• "Interproximal attachment loss on at least two permanent teeth, one of which is a first molar"
• "No more than two teeth other than first molars and incisors"
• "Robust serum antibody response to infecting agents" (LAP) vs. "Poor serum antibody response" (GAP)
• "Generalized interproximal attachment loss affecting at least three permanent teeth other than first molars and incisors"
• "Arc-shaped loss of alveolar bone extending from the distal surface of the second premolar to the mesial surface of the second molar"
• "Mirror image pattern" (bilateral symmetry)
• "Distolabial migration of the maxillary incisors with concomitant diastema formation"
• "Amounts of microbial deposits inconsistent with severity of periodontal tissue destruction"
• "Rate of bone loss is about three to four times faster than in chronic periodontitis"
• "Burnout phenomenon" (self-arresting)
• "N-formyl-methionyl-leucyl-phenylalanine (FMLP)"
• "GP110" (glycoprotein deficiency in LAP neutrophils)
• "IgG2" (dominant serum antibody in LAP; protective)
• "Gene of major effect" (autosomal dominant)
• "Episodic nature of destruction" (GAP)
• "Systemic antibiotics only as adjunct to mechanical debridement" (biofilm effect)
• "Metronidazole + Amoxicillin" (current first-line combination)
• "Tetracycline HCl 250 mg QID for at least 1 week"
• "Familial aggregation"
• "Early-onset periodontitis (EOP)" - former classification
• "Baer's definition" of juvenile periodontitis (1971)

---

BIBLIOGRAPHY (from Uploaded References)

1. Newman MG, Carranza FA et al. Carranza's Clinical Periodontology, 10th Edition. Elsevier, 2006-07. Chapter 33 (Aggressive Periodontitis - Novak KF and Novak MJ), Chapter 28, Chapter 36, Chapter 40, Chapter 46.
2. Lang NP, Lindhe J (eds.). Clinical Periodontology and Implant Dentistry, 6th Edition. Wiley-Blackwell, 2015. Chapter 21 (Aggressive Periodontitis - Tonetti MS and Mombelli A).
3. Newman MG, Carranza FA et al. Newman and Carranza's Clinical Periodontology and Implantology, 14th Edition. Elsevier, 2023. Chapter 11 (Genetic Aspects), Chapter 39.
4. Reddy S. Essentials of Clinical Periodontology and Periodontics. Chapter 26 (Aggressive Periodontitis).
5. Lang N, Bartold PM, Cullinan M et al. Consensus Report: Aggressive Periodontitis. Ann Periodontol. 1999;4:53. [Cited in Carranza 10th ed., Ch. 33; Lang-Lindhe 6th ed., Ch. 21]

---

What These Notes Cover (Section Index)

DISCUSS THE CHOICE OF TREATMENT FOR AGGRESSIVE PERIODONTITIS

Comprehensive Postgraduate Theory Examination Notes

Sources cited throughout:

• Carranza 10th ed. = Carranza's Clinical Periodontology, 10th Edition (Newman MG, Elsevier, 2006-07), Chapter 46 (Treatment of Aggressive and Atypical Forms of Periodontitis)
• Lang-Lindhe 6th ed. = Clinical Periodontology and Implant Dentistry, 6th Edition (Lang NP, Lindhe J, eds., Wiley-Blackwell, 2015), Chapter 21
• S. Reddy Essentials = Essentials of Clinical Periodontology and Periodontics, Chapter 26
• Antibiotics text = Antibiotics and Antiseptics in Periodontal Therapy
• Pharmacology text = Pharmacology and Therapeutics for Dentistry, 7th Edition (Dowd, Johnson, Mariotti, Elsevier, 2017), Chapter 33
• Periodontics MSI = Periodontics: Medicine, Surgery and Implants

---

1. GENERAL PRINCIPLES AND PHILOSOPHY OF TREATMENT

• "Aggressive periodontitis, by definition, causes rapid destruction of the periodontal attachment apparatus and the supporting alveolar bone. The responsiveness of aggressive periodontitis to conventional periodontal treatment is unpredictable, and the overall prognosis for these patients is poorer than for patients with chronic periodontitis." [Carranza 10th ed., Ch. 46]
• "Treatment of aggressive periodontitis must be pursued with a logical and regimented approach." [Carranza 10th ed., Ch. 46]
• "Successful treatment of AgP is considered to be dependent on early diagnosis, directing therapy towards elimination or suppression of the infecting microorganisms and providing an environment conducive to long-term maintenance. The differential element of treatment of AgP, however, relates to specific efforts to affect the composition and not only the quantity of the subgingival microbiota." [Lang-Lindhe 6th ed., Ch. 21]
• "Treatment of aggressive periodontitis should only be initiated after completion of a careful diagnosis by a specifically trained periodontist. The severity of some of the AgP forms suggests that specialists, possibly working in association with highly specialized centers, could best perform both diagnosis and treatment." [Lang-Lindhe 6th ed., Ch. 21]
• "In most patients, aggressive periodontitis can be successfully treated with conventional therapy, and clinicians need to combine a wide range of therapeutic procedures to increase the chances of disease resolution." [Carranza 10th ed., Ch. 46]
• "Treatment for aggressive periodontitis is directed toward controlling subgingival biofilms. In many cases, successful treatment requires mechanical disruption of the biofilms supplemented with systemic antibiotics." [Periodontics MSI]

---

2. ESSENTIAL THERAPEUTIC GOALS

1. Control the infection
2. Arrest disease progression
3. Correct anatomic defects
4. Replace missing teeth
5. Help the patient maintain periodontal health with frequent periodontal maintenance care

• "Early detection is critically important in the treatment of aggressive periodontitis (generalized or localized) because preventing further destruction is often more predictable than attempting to regenerate lost supporting tissues." [Carranza 10th ed., Ch. 46]
• "Early diagnosis, intervention, and, if possible, prevention of disease are more desirable than attempting to reverse the destruction that results from aggressive periodontitis." [Carranza 10th ed., Ch. 46]
• "Educating family members is another important factor because aggressive periodontitis is known to have familial aggregation. Thus, family members, especially younger siblings, of the patient diagnosed with aggressive periodontitis should be examined for signs of disease, educated about preventive measures, and monitored closely." [Carranza 10th ed., Ch. 46]

---

3. PROGNOSIS CONSIDERATIONS BEFORE TREATMENT PLANNING

• Prognosis depends on:
  1. Whether the disease is generalized or localized
  2. The degree of destruction present at the time of diagnosis
  3. The ability to control future progression
• "Generalized aggressive periodontitis rarely undergoes spontaneous remission, whereas localized forms of the disease have been known to arrest spontaneously. This unexplained curtailment of disease progression has sometimes been referred to as a 'burnout' of the disease." [Carranza 10th ed., Ch. 46]
• "Overall, patients with generalized aggressive periodontitis tend to have a poorer prognosis because they typically have more teeth affected by the disease and because the disease is less likely to go spontaneously into remission." [Carranza 10th ed., Ch. 46]

---

4. TREATMENT OPTIONS - OVERVIEW

Flowchart 1: Overview of Treatment Modalities for Aggressive Periodontitis

TREATMENT OF AGGRESSIVE PERIODONTITIS
                    |
    ________________↓___________________
    |                |                 |
CONVENTIONAL    ANTIMICROBIAL      HOST MODULATION
THERAPY         THERAPY            THERAPY
    |                |                 |
• Patient        Systemic:         • Subantimicrobial
  education      • Tetracyclines     dose doxycycline
• OHI            • Amoxicillin +     (SDD)
• SRP              Metronidazole   • NSAIDs
• Surgical       • Metronidazole   • Etoricoxib
  therapy          alone           • Flurbiprofen
  (Resective/    Local delivery:   • Naproxen
  Regenerative)  • Local drug
• Full-mouth       delivery systems
  disinfection       |
                     |
          RESTORATIVE CONSIDERATIONS
                     |
          • Implant placement
          • Tooth transplantation
          • Ridge maintenance
                     |
          MAINTENANCE PHASE
          (Recall every 3 months)

---

5. CONVENTIONAL PERIODONTAL THERAPY

• "Conventional periodontal therapy for aggressive periodontitis consists of patient education, oral hygiene improvement, scaling and root planing, and regular (frequent) recall maintenance. It may or may not include periodontal flap surgery." [Carranza 10th ed., Ch. 46]
• "Unfortunately, the response of aggressive periodontitis to conventional therapy alone has been limited and unpredictable." [Carranza 10th ed., Ch. 46]
• "Patients who are diagnosed with aggressive periodontitis at an early stage and who are able to enter therapy may have a better outcome than those who are diagnosed at an advanced stage. In general, the earlier the disease is diagnosed, the more conservative the therapy and the more predictable the outcome." [Carranza 10th ed., Ch. 46]
• "Mechanical debridement with scaling and root planing can reduce total supragingival and subgingival bacterial masses, but major periodontal pathogens may persist." [Carranza 10th ed., Ch. 46]

---

6. SURGICAL THERAPY

6A. SURGICAL RESECTIVE THERAPY

• "Resective periodontal surgery can be effective to reduce or eliminate pocket depth in patients with aggressive periodontitis." [Carranza 10th ed., Ch. 46]
• "However, it may be difficult to accomplish if adjacent teeth are unaffected, as often seen in cases of localized aggressive periodontitis. If a significant height discrepancy exists between the periodontal support of the affected tooth and the adjacent unaffected tooth, the gingival transition (following the bone) will often result in deep probing pocket depth around the affected tooth despite surgical efforts." [Carranza 10th ed., Ch. 46]
• "It is important to realize the limitations of surgical therapy and to appreciate the possible risk that surgical therapy may further compromise teeth that are mobile because of extensive loss of periodontal support. For example, in a patient with severe horizontal bone loss, surgical resective therapy may result in increased tooth mobility that is difficult to manage, and a nonsurgical approach may be indicated." [Carranza 10th ed., Ch. 46]
• "Careful evaluation of the risks versus the benefits of surgery must be considered on a case-by-case basis." [Carranza 10th ed., Ch. 46]

6B. REGENERATIVE THERAPY

• "Periodontal regenerative procedures have been successfully demonstrated in patients with localized aggressive periodontitis in some clinical case reports." [Carranza 10th ed., Ch. 46]
• Dodson et al. demonstrated "the regenerative potential of a severe, localized osseous defect around a mandibular incisor in a healthy, 19-year-old black man diagnosed with localized aggressive periodontitis." Using open-flap surgical debridement, root surface conditioning (tetracycline solution), and an allogenic bone graft reconstituted with sterile saline and tetracycline powder, the surgeons reduced the probing pocket depth from 9 to 12 mm down to 1 to 3 mm, and significant bone fill of the defect (about 80%) was reported. [Carranza 10th ed., Ch. 46]
• "The authors cited several factors that likely contributed to the success of this case, including:
  1. A probable transition of disease activity from aggressive to chronic
  2. Tooth stabilization before surgery
  3. Sound surgical management of hard and soft tissues
  4. Good postoperative care" [Carranza 10th ed., Ch. 46]
• "Although the potential for regeneration in patients with aggressive periodontitis appears to be good, expectations are limited for patients with severe bone loss. Depending on the anatomy of the defect and teeth involved, the potential for bone fill and periodontal regeneration may be poor. This is especially true if the bone loss is horizontal and if it has progressed to involve furcations." [Carranza 10th ed., Ch. 46]
• "The usual criteria of case selection and sound principles of surgical management for regenerative therapy apply equally to cases of aggressive periodontitis." [Carranza 10th ed., Ch. 46]

• "No evidence has been reported to suggest significant advantages for the use of enamel matrix proteins in patients with aggressive periodontitis... the authors concluded that enamel matrix proteins offered no advantage over surgical debridement alone in these patients. At this time, it is unknown whether the use of enamel matrix proteins offers significant advantages for the patient with aggressive periodontitis." [Carranza 10th ed., Ch. 46]

---

7. ANTIMICROBIAL THERAPY

7A. RATIONALE FOR ANTIBIOTICS IN AGGRESSIVE PERIODONTITIS

• "The presence of periodontal pathogens, specifically Actinobacillus actinomycetemcomitans, has been implicated as the reason that aggressive periodontitis does not respond to conventional therapy alone. These pathogens are known to remain in the tissues after therapy to reinfect the pocket." [Carranza 10th ed., Ch. 46]
• "The use of systemic antibiotics was thought to be necessary to eliminate pathogenic bacteria (especially A. actinomycetemcomitans) from the tissues." [Carranza 10th ed., Ch. 46]
• "Several investigators have reported that scaling and root planing of juvenile periodontitis lesions could not predictably suppress A. actinomycetemcomitans below detection levels." [Lang-Lindhe 6th ed., Ch. 21]
• "Soft tissue curettage and access flap therapy also had limited success in eliminating A. actinomycetemcomitans." [Lang-Lindhe 6th ed., Ch. 21]
• "A. actinomycetemcomitans is also difficult to eliminate by conventional mechanical therapy in adult periodontitis patients." [Lang-Lindhe 6th ed., Ch. 21]
• "It is especially important to consider antibiotic therapy in the treatment of aggressive periodontitis, which often involves several specific pathogens with the potential to invade pocket epithelium and connective tissue." [Antibiotics text]
• "Systemic antibiotics should only be administered as an adjunct to mechanical debridement because in undisturbed subgingival plaque, the target organisms are effectively protected from the antibiotic agent due to the biofilm effect." [Lang-Lindhe 6th ed., Ch. 21]

7B. SYSTEMATIC EVIDENCE FOR ANTIBIOTICS

• "There is compelling evidence that adjunctive antibiotic treatment frequently results in a more favorable clinical response than mechanical therapy alone. In a systematic review, Herrera et al. found that systemic antimicrobials in conjunction with scaling and root planing offer benefits over scaling and planing alone in terms of clinical attachment level, probing pocket depth, and reduced risk of additional attachment loss. Patients with deeper, progressive pockets seem to benefit the most from systemic administration of adjunctive antibiotics." [Carranza 10th ed., Ch. 46]
• "Haffajee et al. concluded that a systemically administered combination of antibiotics (amoxicillin and metronidazole) with periodontal therapy (scaling and root planing and/or surgery) provided better disease control in difficult-to-manage periodontitis cases than similar periodontal therapy without antibiotics." [Carranza 10th ed., Ch. 46]
• "Some patient categories with recognized increased risk for periodontal breakdown, such as progressive adolescent periodontitis and other types of early onset periodontitis, may be treated with systemic antibiotics as an adjunct to initial mechanical therapy." [Antibiotics text]

7C. CHOICE OF ANTIBIOTIC - TWO APPROACHES

1. Empiric (based on published information on the efficacy of the regimen in similar populations)
2. Guided by information about the nature of the involved pathogenic microorganism(s) and/or their antibiotic susceptibility profile.

---

8. SPECIFIC ANTIBIOTIC REGIMENS

Table 1: Antibiotic Therapy for Aggressive Periodontitis (Carranza 10th Ed., Table 46-1)

---

8A. TETRACYCLINES

• "Systemic tetracycline (250 mg of tetracycline hydrochloride four times daily for at least 1 week) should be given in conjunction with local mechanical therapy."
• "If surgery is indicated, systemic tetracycline should be prescribed and the patient instructed to begin taking the antibiotic approximately 1 hour before surgery."
• "Doxycycline, 100 mg/day, may be used instead of tetracycline."
• "Chlorhexidine rinses should be prescribed and continued for several weeks to enhance plaque control and facilitate healing."
• "The criteria for selection of antibiotics are not clear. Good clinical and microbiologic responses have been reported with several individual antibiotics and antibiotic combinations. The optimal antibiotic or combination for any particular infection probably depends on the case. Choices must be made based on patient-related and disease-related factors." [Carranza 10th ed., Ch. 46]

• "Genco and coworkers reported scaling and root planing and tetracycline 250 mg qid for 14 days every 8 weeks. Several other investigations have also noticed excellent bone fill in cases of LJP treated with tetracycline, flap surgery and placement of grafts." [S. Reddy Essentials, Ch. 26]

• "Results obtained following adjunctive use of tetracycline in the treatment of localized aggressive periodontitis were often clinically profound. Such improvements were likely due to the elimination or severe repression of A. actinomycetemcomitans in the infected site." [Antibiotics text]
• "Christersson et al. showed that systemic tetracycline-HCl alone has beneficial effects on clinical parameters in localized juvenile periodontitis patients and can suppress A. actinomycetemcomitans. However, A. actinomycetemcomitans was suppressed below detectable levels in only approximately 50% of the lesions even following an 8-week tetracycline administration." [Antibiotics text]
• "Noval et al. demonstrated that in early identified lesions of localized juvenile periodontitis the therapy with systemically administered tetracycline alone (1 gm/day for 6 weeks) resulted in the arrest of disease progression, decreased PPDs (from 7.1 to 3.6 mm), gains in clinical attachment (from 3.8 to 0.9 mm), and significant repair of alveolar defects (angular bone defects had filled by an average of 72%), up to 4 years after the completion of tetracycline therapy." [Antibiotics text]

• "Both doxycycline and minocycline, like tetracycline, may significantly suppress A. actinomycetemcomitans but not totally eradicate the bacterium from all sites." [Antibiotics text]

• "Tetracyclines may be of use in the management of localized aggressive periodontitis and its associated organism, Aggregatibacter (formerly Actinobacillus) actinomycetemcomitans. Tetracyclines also seem to inhibit inflammatory matrix metalloproteinase activity." [Pharmacology text, Ch. 33]
• "The degree of benefit of the use of tetracyclines in periodontal disease has to be weighed against the risk of developing resistant strains of microorganisms." [Pharmacology text, Ch. 33]
• Tetracycline resistance: "Given the possible emergence of tetracycline-resistant A. actinomycetemcomitans, there is concern that tetracycline may not be effective. In these cases the combination of metronidazole and amoxicillin may be advantageous." [Carranza 10th ed., Ch. 46]

---

8B. AMOXICILLIN + METRONIDAZOLE (Current First-Line Combination)

1. Achievement of adequate supragingival plaque control (<25% of tooth sites with detectable plaque)
2. Rigorous subgingival instrumentation with a combination of hand and ultrasonic instruments completed within 2 days
3. Adjunctive systemic antibiotic regimen: Metronidazole 500 mg TID + Amoxicillin 500 mg TID for 7 days

• "The results of the placebo arm showed highly significant improvements in clinical parameters, including reductions of probing depth and improvement of clinical attachment levels throughout the dentition. The adjunctive antibiotic provided additional benefits in the deeper pockets for all parameters." [Lang-Lindhe 6th ed., Ch. 21]
• "A follow-up analysis... showed benefit from the earlier administration [of antibiotics concurrent with SRP]." [Lang-Lindhe 6th ed., Ch. 21]

• After SRP + amoxicillin 500 mg + metronidazole 500 mg TID × 7 days in patients with GAP:
  • "Highly significant treatment effects for full-mouth PPD reduction, PPD reduction at 4-6 mm pockets, and PPD reduction at ≥7 mm pockets at 2 and 6 months"
  • In deeper pockets (≥7 mm): adjusted difference between test and placebo was 0.9 mm at 2 months and 1.4 mm at 6 months for PPD reduction
  • CAL gain at ≥7 mm: 0.6 mm at 2 months and 1.0 mm at 6 months [Antibiotics text]

• "Combination of metronidazole with a β-lactam antibiotic for oral infections may be indicated for serious acute orofacial infections and in the management of aggressive periodontitis." [Pharmacology text, Ch. 33]
• "The combination of metronidazole with amoxicillin may significantly enhance its activity against A. actinomycetemcomitans, apparently by increasing cellular uptake of metronidazole." [Pharmacology text, Ch. 33]
• "A. actinomycetemcomitans, E. corrodens, Actinomyces, and Propionibacterium are commonly resistant to metronidazole." [Pharmacology text, Ch. 33]

• "Adjunctive metronidazole alone (when A. actinomycetemcomitans is not involved) is effective in deep pockets of aggressive periodontitis patients." [Antibiotics text]

---

8C. TWO APPROACHES TO ANTIBIOTIC USE IN AgP (Lang-Lindhe 6th ed.)

Table 2: Two Validated Approaches to Antibiotic Administration in AgP

---

8D. MICROBIAL TESTING AND ANTIBIOTIC SELECTION

• "Some investigators and clinicians advocate microbial testing as a necessary means of identifying the specific periodontal pathogens responsible for disease and to select an appropriate antibiotic based on sensitivity and resistance." [Carranza 10th ed., Ch. 46]
• "There may be specific cases in which bacterial identification and antibiotic-sensitivity testing is invaluable. For example, in localized aggressive periodontitis cases, tetracycline-resistant Actinobacillus species have been suspected. If antibiotic susceptibility tests determine that tetracycline-resistant species exist in the lesion, the clinician may be advised to consider another antibiotic or an antibiotic combination, such as amoxicillin and metronidazole." [Carranza 10th ed., Ch. 46]
• "An accurate identification of periodontal pathogens and their antibiotic sensitivities is more important when the disease is not responding to the given antibiotics and periodontal therapy." [Carranza 10th ed., Ch. 46]
• "Microbiologic testing, if performed, may be repeated 1-3 months after completion of therapy to verify the elimination or marked suppression of the putative pathogen(s)." [Lang-Lindhe 6th ed., Ch. 21]

---

8E. LOCAL DELIVERY

• "The use of local delivery to administer antibiotics offers a novel approach to the management of periodontal 'localized' infections."
• "The primary advantage of local therapy is that smaller total dosages of topical agents can be delivered inside the pocket, avoiding the side effects of systemic antibacterial agents while increasing the exposure of the target microorganisms to higher concentrations, and therefore more therapeutic levels, of the medication."
• "Local delivery agents have been formulated in many different forms, including solutions, gels, fibers, and chips." [Carranza 10th ed., Ch. 46]

---

9. FULL-MOUTH DISINFECTION (FMD)

• "Another approach to antimicrobial therapy in the control of infection associated with periodontitis is the concept of full-mouth disinfection. The concept, described by Quirynen et al., consists of full-mouth debridement (removal of all plaque and calculus) completed in two appointments within a 24-hour period." [Carranza 10th ed., Ch. 46]
• "In addition to scaling and root planing:
  1. The tongue is brushed with a chlorhexidine gel (1%) for 1 minute
  2. The mouth is rinsed with a chlorhexidine solution (0.2%) for 2 minutes
  3. Periodontal pockets are irrigated with a chlorhexidine solution (1%)" [Carranza 10th ed., Ch. 46]
• Evidence in AgP: "De Soete et al. found a significant reduction in probing pocket depth and gain in clinical attachment in patients with aggressive periodontitis up to 8 months after treatment compared with controls (scaling and root planing by quadrant at 2-week intervals). They also found significant reductions in periodontal pathogens up to 8 months after therapy. Porphyromonas gingivalis and Tannerella forsythia (formerly Bacteroides forsythus) were reduced to levels below detection." [Carranza 10th ed., Ch. 46]
• "Treatment of aggressive periodontitis also includes full mouth disinfection, which has been proposed by Quirynen et al. Since it was observed that A. actinomycetemcomitans has the ability to translocate from one person to another and from site to site, full mouth disinfection was implemented." [S. Reddy Essentials, Ch. 26]

Full-Mouth Disinfection Steps (S. Reddy Essentials):

1. Full mouth scaling and root planing (in two sessions within 24 hours)
2. Brushing the dorsum of the tongue with an antimicrobial agent (1% chlorhexidine gel) for 1 minute
3. Mouthrinsing with antimicrobial agents
4. Home irrigation systems

---

10. HOST MODULATION THERAPY

• "Currently, the influence of the host immune response in the pathogenesis of periodontitis is well known. Variations in host response between individuals are greatly responsible for observed differences in disease severity. This is especially true for individuals with aggressive periodontitis." [Carranza 10th ed., Ch. 46]
• "A novel approach in the treatment of aggressive periodontitis and difficult-to-control forms of periodontal disease is the administration of agents that modulate the host response." [Carranza 10th ed., Ch. 46]

10A. Subantimicrobial-Dose Doxycycline (SDD)

• "The use of subantimicrobial-dose doxycycline (SDD) may help to prevent the destruction of the periodontal attachment by controlling the activation of matrix metalloproteinases, primarily collagenase and gelatinase, from both infiltrating cells and resident cells of the periodontium, primarily the neutrophils." [Carranza 10th ed., Ch. 46]
• "SDD as an adjunct to repeated mechanical debridement resulted in clinical improvement in patients with generalized aggressive periodontitis. More than 50% of the patients in this study were smokers." [Carranza 10th ed., Ch. 46]

10B. NSAIDs

• "Other agents, such as flurbiprofen, indomethacin, and naproxen, may reduce inflammatory mediator production. Further research needs to be done to substantiate the effects of these agents." [Carranza 10th ed., Ch. 46]
• Adjunctive etoricoxib in non-surgical treatment of aggressive periodontitis: short-term benefit reported. [Antibiotics text]

---

11. HISTORICAL TREATMENT APPROACHES (S. Reddy Essentials, Ch. 26)

Table 3: Historical Treatment Approaches for Aggressive Periodontitis

• "In almost all cases, systemic tetracycline hydrochloride 250 mg qid for at least a week should be given in conjunction with local mechanical therapy. If surgery is indicated, systemic antibiotics are advised with patient instructed to begin taking the antibiotic approximately 1 hour before surgery."
• "Doxycycline 100 mg/day may also be used."
• "Chlorhexidine rinses should be prescribed."
• "In refractory cases, tetracycline resistant Aggregatibacter species have been suspected. In such cases, a combination of amoxicillin and metronidazole has been suggested." [S. Reddy Essentials, Ch. 26]

---

12. RESTORATIVE CONSIDERATIONS AND TOOTH REPLACEMENT

• "Successful management of patients with aggressive periodontitis must include tooth replacement as part of the treatment plan." [Carranza 10th ed., Ch. 46]
• "In some advanced cases of aggressive periodontitis, the overall treatment success for the patient may be enhanced if severely compromised teeth are extracted. The outcome of treatment for these teeth is limited, and more importantly, the retention of severely diseased teeth over time may result in additional bone loss." [Carranza 10th ed., Ch. 46]
• "The risk of further bone loss is even a greater concern now with the current success and predictability of dental implants and the desire to preserve bone for implant placement." [Carranza 10th ed., Ch. 46]
• "Healing of extraction sites is typically uneventful in patients with aggressive periodontitis, and bone augmentation of defect sites is predictable." [Carranza 10th ed., Ch. 46]
• The fundamental approach: "Extract severely compromised teeth early, and plan treatment to accommodate future tooth loss. The teeth with the best prognosis should be identified and considered when planning the restorative treatment." [Carranza 10th ed., Ch. 46]
• "The lower cuspids and first premolars are generally more resistant to loss, probably because of the favorable anatomy (single roots, no furcations) and easier access for patient oral hygiene." [Carranza 10th ed., Ch. 46]
• "As a rule, an extensive fixed prosthesis should be avoided, and removable partial dentures should be planned in such a way as to allow for the addition of teeth." [Carranza 10th ed., Ch. 46]
• "Transplantation of developing third molars to the sockets of hopeless first molars has been attempted with limited success." [Carranza 10th ed., Ch. 46]

---

13. USE OF DENTAL IMPLANTS

• "Initially, the use of dental implants was suggested and implemented with much caution in patients with aggressive periodontitis because of an unfounded fear of bone loss. However, evidence to the contrary appears to support the use of dental implants in patients with aggressive periodontal disease." [Carranza 10th ed., Ch. 46]
• "Currently, the use of dental implants must be considered in the overall treatment plan for patients with aggressive periodontitis." [Carranza 10th ed., Ch. 46]

---

14. PERIODONTAL MAINTENANCE (SUPPORTIVE PERIODONTAL THERAPY)

• "When patients with aggressive periodontitis are transferred to maintenance care, their periodontal condition must be stable (i.e., no clinical signs of disease and no periodontal pathogens)." [Carranza 10th ed., Ch. 46]
• "Each maintenance visit should consist of: medical history review, inquiry about recent changes in medications, clinical examination including radiographs as indicated, oral hygiene assessment, debridement." [Carranza 10th ed., Ch. 46]
• "In a 5-year follow-up study of 13 patients with aggressive periodontitis, comprehensive mechanical, surgical, and antimicrobial therapy with supportive periodontal maintenance every 3 to 4 months, periodontal disease progression was arrested in 95% of the initially affected lesions. Only 2% to 5% experienced discrete episodes of loss of periodontal support." [Carranza 10th ed., Ch. 46]
• Duration between recall visits: "Generally no longer than 3-month intervals during the first period after the patient's completion of therapy."
• "Monitoring as frequently as every 3 to 4 weeks may be necessary when the disease is thought to be active." [Carranza 10th ed., Ch. 46]
• "If signs of disease activity and progression persist despite therapeutic efforts, frequent visits and good patient compliance, microbial testing may be indicated." [Carranza 10th ed., Ch. 46]
• "The rate of disease progression may be faster in younger individuals, and therefore the clinician should monitor such patients more frequently." [Carranza 10th ed., Ch. 46]
• "Close collaboration between members of the treatment team, including the periodontist, general dentist, dental hygienist, and patient's physician, is required for continuity of care." [Carranza 10th ed., Ch. 46]
• "It is important to monitor and observe the patient's overall physical status as well, because weight loss, depression, and malaise have been reported in patients with generalized aggressive periodontitis." [Carranza 10th ed., Ch. 46]
• "Recurrence of disease is an indication for a repeat of the microbiologic tests, re-evaluation of the host immune response, and reassessment of the local and systemic modifying factors. Further therapy should be targeted against putative periodontal pathogens and should take into account the systemic immune responses of the subject." [Lang-Lindhe 6th ed., Ch. 21]

---

15. TREATMENT SUMMARY FLOWCHART (Comprehensive)

Flowchart 2: Step-by-Step Treatment Protocol for Aggressive Periodontitis

DIAGNOSIS OF AGGRESSIVE PERIODONTITIS
(Specialist - Periodontist)
              |
              ↓
STEP 1: PATIENT EDUCATION AND MOTIVATION
• Explain disease, causes, risk factors
• Stress patient's role in treatment success
• Examine and educate family members (familial aggregation)
• Screen younger siblings
              |
              ↓
STEP 2: INITIAL/CAUSE-RELATED THERAPY
• Oral hygiene instruction
• Supragingival plaque control
  (Target: < 25% sites with detectable plaque)
• Full-mouth SRP (ideally within 2 days)
  [APPROACH 1: Concurrent antibiotic - see Step 3A]
  [APPROACH 2: Staged - reassess after 3-6 months]
              |
              ↓
STEP 3A: ADJUNCTIVE SYSTEMIC ANTIBIOTIC THERAPY
(CONCURRENT WITH STEP 2 - Best evidence)
   ┌─────────────────────────────────────────────┐
   │ FIRST CHOICE:                               │
   │ Amoxicillin 500 mg TID + Metronidazole      │
   │ 500 mg TID × 7 days                         │
   │ (Validated RCTs: Guerrero 2005 et al.)      │
   ├─────────────────────────────────────────────┤
   │ ALTERNATIVE (LAP/Aa-associated):            │
   │ Tetracycline HCl 250 mg QID × ≥ 1 week     │
   │ OR Doxycycline 100 mg/day                   │
   ├─────────────────────────────────────────────┤
   │ IF TETRACYCLINE-RESISTANT:                  │
   │ Amoxicillin + Metronidazole                 │
   ├─────────────────────────────────────────────┤
   │ IF Aa NOT INVOLVED:                         │
   │ Metronidazole alone (500 mg TID × 7 days)   │
   └─────────────────────────────────────────────┘
   Adjunct: Chlorhexidine rinses × several weeks
              |
              ↓
STEP 4: REASSESSMENT
• 3-6 months post-initial therapy
• Microbiologic testing if indicated
• Assess residual pockets, bone levels
              |
              ↓
STEP 5: SURGICAL PHASE (if indicated)
• Resective surgery: to reduce/eliminate residual pockets
  (Caution in LAP - adjacent height discrepancy)
• Regenerative surgery: bone grafts + barrier membranes
  (Best for angular/intrabony defects; limited for
  horizontal loss or furcation involvement)
• Begin antibiotic 1 hour before surgery
• Local delivery systems for localized sites
              |
              ↓
STEP 6: EXTRACT HOPELESS TEETH
• Extract early to preserve bone for implants
• Lower cuspids/first premolars: most resistant to loss
• Avoid extensive fixed prosthesis
• Plan removable partial dentures for future additions
              |
              ↓
STEP 7: HOST MODULATION (adjunct)
• SDD (subantimicrobial dose doxycycline)
• Full-mouth disinfection (Quirynen protocol)
              |
              ↓
STEP 8: MAINTENANCE PHASE
• Recall every 3-4 months (minimum)
• Every 3-4 weeks if disease active
• Monitor microbiologically
• Reassess and re-treat if recurrence
• 5-yr follow-up: 95% lesion arrest with this regimen

---

16. TREATMENT OF REFRACTORY AGGRESSIVE PERIODONTITIS

• "Patients with periodontitis that is refractory to treatment often present with a history of previous tetracycline therapy, and thus they may have a microflora that is resistant to this drug." [Carranza 10th ed., Ch. 46]
• "For patients with refractory disease who fail to respond to initial antibiotic therapy, subsequent treatment should include microbial testing with bacterial identification and antimicrobial susceptibility." [Carranza 10th ed., Ch. 46]
• "Antibiotic resistance is a potential problem." [Carranza 10th ed., Ch. 46]
• "Cases of periodontitis (refractory) in which the associated microflora consists primarily of gram-positive microorganisms have been successfully treated with amoxicillin-clavulanate potassium. A regimen of 250 mg of amoxicillin and 125 mg of clavulanate potassium, administered three times daily for 14 days, with scaling and root planing." [Carranza 10th ed., Ch. 46]
• "Clindamycin is a potent antibiotic that penetrates well into gingival fluid. A regimen of clindamycin hydrochloride, 150 mg, four times daily for 7 days combined with scaling and root planing produced a decrease in the incidence of disease activity from an annual rate of 8% to an annual rate of 0.5% of sites per patient. Clindamycin should be prescribed with caution because of the potential for pseudomembranous colitis from superinfections with Clostridium difficile." [Carranza 10th ed., Ch. 46]
• "Azithromycin may be effective in periodontitis that is refractory to treatment, especially in patients infected with P. gingivalis." [Carranza 10th ed., Ch. 46]
• "A regimen of 500 mg of metronidazole three times daily for 7 days was shown to be effective in treating periodontitis (refractory) in patients who were culture positive for T. forsythia in the absence of A. actinomycetemcomitans." [Carranza 10th ed., Ch. 46]

---

17. DIFFERENT VIEWPOINTS ACROSS REFERENCES

Table 4: Comparison of Treatment Viewpoints Across Uploaded References

---

18. EXAMINER KEYWORDS SUMMARY

Key terms and phrases for examination answers:

• "Logical and regimented approach"
• "Unpredictable response to conventional therapy alone"
• "Specific efforts to affect the composition and not only the quantity of the subgingival microbiota"
• "Biofilm effect" (reason antibiotics must be adjunct to SRP)
• "Tetracycline HCl 250 mg QID for at least 1 week" (BOX 46-1)
• "Begin antibiotic approximately 1 hour before surgery"
• "Doxycycline 100 mg/day" (alternative to tetracycline)
• "Chlorhexidine rinses for several weeks"
• "Amoxicillin + metronidazole" (for tetracycline-resistant strains)
• "500 mg amoxicillin + 500 mg metronidazole TID × 7 days" (Guerrero et al. - first-line with RCT evidence)
• "Full-mouth debridement within 24 hours" (full-mouth disinfection)
• "1% chlorhexidine gel - tongue brushing"
• "Subantimicrobial-dose doxycycline (SDD)"
• "Burnout phenomenon" (spontaneous arrest in LAP)
• "Transplantation of developing third molars - limited success"
• "Extract severely compromised teeth early"
• "Lower cuspids and first premolars - most resistant to loss"
• "Avoid extensive fixed prosthesis"
• "Maintenance every 3-4 months; every 3-4 weeks when active"
• "95% of lesions arrested" (5-year follow-up with comprehensive treatment)
• "Microbial testing when disease not responding"
• "Pseudomembranous colitis risk with clindamycin" (Clostridium difficile)
• "Two approaches: empiric vs. guided antibiotic therapy"
• "Early antibiotic administration shows benefit over late" (Guerrero et al.)

---

19. CONCLUSION: SCIENCE TRANSFER (Carranza 10th ed., Ch. 46)

---

BIBLIOGRAPHY (from Uploaded References)

1. Newman MG, Carranza FA et al. Carranza's Clinical Periodontology, 10th Edition. Elsevier, 2006-07. Chapter 46: Treatment of Aggressive and Atypical Forms of Periodontitis (primary treatment source).
2. Lang NP, Lindhe J (eds.). Clinical Periodontology and Implant Dentistry, 6th Edition. Wiley-Blackwell, 2015. Chapter 21 (Tonetti MS, Mombelli A) - Principles of Therapeutic Intervention.
3. Reddy S. Essentials of Clinical Periodontology and Periodontics. Chapter 26.
4. Antibiotics and Antiseptics in Periodontal Therapy. Sections 3.6, 3.8, 3.13 (Guerrero et al. RCT data; tetracycline in LAP; Herrera systematic review).
5. Dowd FJ, Johnson BS, Mariotti AJ. Pharmacology and Therapeutics for Dentistry, 7th Edition. Elsevier, 2017. Chapter 33 (metronidazole and tetracycline therapeutic uses in periodontitis).
6. Periodontics: Medicine, Surgery and Implants. Chapter on Aggressive Periodontitis (treatment directed toward controlling subgingival biofilms).These are your complete postgraduate examination notes on "Discuss the Choice of Treatment for Aggressive Periodontitis", extracted exclusively from your uploaded references. Here is a section index:

---

Section Index

RECENT CONCEPTS IN ETIOPATHOGENESIS OF AGGRESSIVE PERIODONTITIS

Comprehensive Postgraduate Theory Examination Notes

Sources cited throughout:

• Carranza 10th ed. = Carranza's Clinical Periodontology, 10th Edition (Newman MG, Elsevier, 2006-07), Chapters 7, 11, 33
• Newman-Carranza 14th ed. = Newman and Carranza's Clinical Periodontology and Implantology, 14th Edition, Chapters 9, 11
• Lang-Lindhe 6th ed. = Clinical Periodontology and Implant Dentistry, 6th Edition (Lang NP, Lindhe J, Wiley-Blackwell, 2015), Chapter 21
• S. Reddy Essentials = Essentials of Clinical Periodontology and Periodontics, Chapter 26
• Periodontics MSI = Periodontics: Medicine, Surgery and Implants

---

1. INTRODUCTION - PATHOGENESIS OVERVIEW

• "Pathogenesis of aggressive periodontitis is due to an interplay of several factors. These include the specific microbiology of subgingival plaque, defects in cementum, hereditary factors, impaired polymorphonuclear neutrophils (PMNs) function and disorders of the immune system." [S. Reddy Essentials, Ch. 26]
• "The pathogenesis of periodontal destruction involves a complex interplay between bacterial pathogens and the host tissues. It has been recognized that 'not all dental plaque is equal' and that specific bacterial pathogens appear to be responsible for the changes in disease. It also has been recognized that in the process of effectively limiting the bacterial assault on the periodontal tissues, host defense mechanisms contribute to the destruction of tissues locally." [Carranza 10th ed., Ch. 7]
• "Recent investigations have revealed that not all strains of a specific microbial species are equal in their capacity to cause disease, and not all hosts are equal in their susceptibility to disease. The challenge for the future is to be able to better identify the more virulent bacterial strains and the more susceptible hosts." [Carranza 10th ed., Ch. 7]
• "AgP, however, can occur at any age. Diagnosis of AgP requires exclusion of the presence of systemic diseases that may severely impair host defenses and lead to premature tooth loss." [Lang-Lindhe 6th ed., Ch. 21]
• "Frequently, AgP presents early in the life of the individual; this implies that etiologic agents have been able to cause clinically detectable levels of disease over a relatively short time. This fact is central to the current understanding of these diseases, since it implies infection with a highly virulent microbial biofilm and/or a high level of subject susceptibility to periodontal disease." [Lang-Lindhe 6th ed., Ch. 21]

---

2. FLOWCHART: ETIOPATHOGENESIS OF AGGRESSIVE PERIODONTITIS

Flowchart 1: Overall Etiopathogenesis of Aggressive Periodontitis

ETIOPATHOGENESIS OF AGGRESSIVE PERIODONTITIS
                    |
        ____________↓____________
        |                       |
MICROBIAL FACTORS          HOST FACTORS
        |                       |
        ↓                       ↓
 PRIMARY PATHOGEN          IMMUNE DEFECTS
 Aa (LAP) / Pg (GAP)      PMN Dysfunction
        |                 Monocyte/Macrophage
        ↓                 Hyperresponsiveness
Virulence factors:              |
• Leukotoxin                    ↓
• LPS/Endotoxin           GENETIC FACTORS
• Chemotaxis inhibitors    Autosomal dominant
• Collagenase              major susceptibility
• Bacteriocin              gene (IgG2 modifying)
• Immunosuppressive               |
  factors                         ↓
        |                 ENVIRONMENTAL FACTORS
        ↓                  Cigarette smoking
Tissue invasion of              (GAP)
connective tissue +             Race
bone surface                    |
        |           ____________↓____________
        ↓           |                       |
        ┌───────────┴───────────┐
        ↓                       ↓
LOCAL TISSUE EVENTS        SYSTEMIC RESPONSE
• PMN recruitment          • Serum IgG2 (LAP)
• IL-1α, IL-1β, PGE2       • Poor Ab (GAP)
  elevated in GCF          • HLA-A9, B15
• Collagen degradation
• Bone resorption
        |
        ↓
ATTACHMENT LOSS + BONE LOSS
(3-4x faster than chronic periodontitis)

---

3. MICROBIOLOGICAL FACTORS

3A. PRIMARY PATHOGEN IN LAP: Aggregatibacter actinomycetemcomitans

1. Association studies: "A. actinomycetemcomitans was isolated in periodontal lesions from >90% of LAP patients and was much less frequent in periodontally healthy individuals."
2. Longitudinal studies: "Sites with evidence of disease progression often showed elevated levels of this organism prior to the transition in clinical status."
3. Immune response findings: "Investigators repeatedly reported significantly elevated levels of serum antibodies to A. actinomycetemcomitans in LAP patients."
4. Clinical treatment studies: "Unsuccessful treatment outcomes were linked to a failure in reducing the subgingival load of A. actinomycetemcomitans."

• "A. actinomycetemcomitans has been isolated in up to 97% of LAP patients, compared with 21% of adult periodontitis patients and 17% of healthy subjects."
• "Not only is the prevalence of A. actinomycetemcomitans six times greater in LAP than in healthy patients, but its proportion of the cultivable subgingival flora also is elevated."
• "Among the three serotypes, serotype B is the most common, followed by serotype A." [Carranza 10th ed., Ch. 7]

• "Several studies have provided evidence for transmission of A. actinomycetemcomitans between humans, for example from parent to child or between spouses." [Lang-Lindhe 6th ed., Ch. 21]

• "Not all reports support the association of A. actinomycetemcomitans and localized aggressive periodontitis. In some studies, A. actinomycetemcomitans either could not be detected in patients with this form of disease or could not be detected at the previously reported frequencies. Another study found elevated levels of P. gingivalis, P. intermedia, Fusobacterium nucleatum, C. rectus, and Treponema denticola in patients with either localized or generalized aggressive disease, but no significant association was found between the presence of aggressive disease and A. actinomycetemcomitans. In addition, A. actinomycetemcomitans often can be detected in periodontally healthy subjects, suggesting that this micro-organism may be part of the normal flora in many individuals." [Carranza 10th ed., Ch. 33]

3B. MICROBIAL PROFILE IN LAP VS. GAP

3C. BACTERIAL INVASION OF TISSUES

• "Electron microscopy studies of LAP have revealed bacterial invasion of connective tissue that reaches the bone surface. The invading flora has been described as morphologically mixed but composed mainly of gram-negative bacteria, including cocci, rods, filaments, and spirochetes." [Carranza 10th ed., Ch. 33]
• "Using different methods, including immunocytochemistry, several tissue-invading microorganisms have been identified as A. actinomycetemcomitans, Capnocytophaga sputigena, Mycoplasma species, and spirochetes." [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
• "Investigations in humans have indicated that A. actinomycetemcomitans is able to translocate across the junctional epithelium and invade the underlying connective tissue." [Lang-Lindhe 6th ed., Ch. 21]

3D. HIGHLY LEUKOTOXIC STRAINS OF Aa (Recent Concept)

• "Leukotoxin production varies significantly among strains of A. actinomycetemcomitans. Brogan et al. (1994) detected a 530-bp deletion in the promoter region of the leukotoxin operon and found that strains with this feature produced 10-20 times more leukotoxin." [Lang-Lindhe 6th ed., Ch. 21]
• "Subsequent analysis showed that the occurrence of such highly leukotoxic strains is over-represented in African-American patients with LAP and can be found in patients with aggressive periodontitis of different ethnic origin worldwide." [Lang-Lindhe 6th ed., Ch. 21]
• "These highly leukotoxic strains are capable of killing PMNs at lower concentrations." [Lang-Lindhe 6th ed., Ch. 21]

---

4. VIRULENCE FACTORS OF Aggregatibacter actinomycetemcomitans

Table 1: Virulence Factors of A. actinomycetemcomitans [Lang-Lindhe 6th ed., Table 21-2; S. Reddy Essentials, Table 26.1]

• "A. actinomycetemcomitans produces outer membrane vesicles that are shed from the bacterial surface and can serve as transport vehicles to spread endotoxin as well as other pathogenic substances produced by the bacterium." [Lang-Lindhe 6th ed., Ch. 21]
• "A. actinomycetemcomitans is quite virulent, producing a leukotoxin, collagenase, phosphatases, and bone-resorbing factors, as well as other factors important in invasion of host tissue cells, evasion of host defenses, immunosuppression, and destruction of periodontal tissues." [Carranza 10th ed., Ch. 7]

---

5. IMMUNOLOGICAL FACTORS (HOST RESPONSE)

5A. POLYMORPHONUCLEAR LEUKOCYTE (PMN) DEFECTS

• "Several investigators have shown that patients with aggressive periodontitis display functional defects of polymorphonuclear leukocytes (PMNs), monocytes, or both. These defects can impair either the chemotactic attraction of PMNs to the site of infection or their ability to phagocytose and kill microorganisms." [Carranza 10th ed., Ch. 33]
• "Approximately 75% of patients with LAP have dysfunctional neutrophils, involving a decreased expression of G-protein coupled receptors. The defect is evident as a decrease in the chemotactic response to several agents, including:
  • Complement component C5a
  • N-formyl-methionyl leucyl phenylalanine (FMLP)
  • Leukotriene B4" [Carranza 10th ed., Ch. 7]
• "The defect is associated with a 40% deficiency in a 110-kilodalton membrane glycoprotein, GP110, on the neutrophil surface. The function of GP110 is unknown, but diminished GP110 expression is associated with diminished surface expression of all G-protein coupled receptors. For this reason, this neutrophil defect has been called a 'global membrane receptor defect'." [Carranza 10th ed., Ch. 7]
• "LAP patients (25%) who do not show G-protein coupled receptor deficiency have the same clinical picture as those with this neutrophil defect. This suggests that the G-protein coupled receptor deficiency is sufficient but not essential for LAP, and other alterations of the host-bacterial interaction may yield a similar clinical outcome." [Carranza 10th ed., Ch. 7]
• "A key report has indicated that PMN abnormalities in LAP patients seem to cluster in families, much in the same way as AgP does (Van Dyke et al. 1985). This evidence has been interpreted as a suggestion that the LAP-associated PMN defect may be inherited." [Lang-Lindhe 6th ed., Ch. 21]
• "Other reports have indicated that PMN abnormalities in LAP patients may be, at least in part, the result of a hyperinflammatory state resulting in the presence of pro-inflammatory cytokines in the serum of some AgP patients." [Lang-Lindhe 6th ed., Ch. 21]

5B. MATRIX METALLOPROTEINASES (MMPs) IN AgP - RECENT CONCEPT

• "In LAP the predominant collagenase found in tissues and crevicular fluid is MMP-1, and elevated levels of TIMP-1 are present."
• "This contrasts with the situation in chronic periodontitis, in which the collagenous activity is caused by MMP-8 from neutrophils."
• "The differences in MMPs may relate to altered neutrophil functions and further underscore the evidence that varying mechanisms of tissue destruction occur in these different forms of periodontal destruction." [Carranza 10th ed., Ch. 7]

5C. MONOCYTE/MACROPHAGE HYPERRESPONSIVENESS

• "Current studies have also demonstrated a hyperresponsiveness of monocytes from LAP patients involving their production of prostaglandin E2 (PGE2) in response to lipopolysaccharide (LPS). This hyperresponsive phenotype could lead to increased connective tissue or bone loss caused by excessive production of these catabolic factors." [Carranza 10th ed., Ch. 33]
• "Local inflammatory responses are characterized by high levels of PGE2, IL-1α, and IL-1β in both crevicular fluid and tissue. PGE2 production, in particular, has been shown to be highly elevated in AgP subjects when compared to periodontally healthy individuals and patients with chronic periodontitis." [Lang-Lindhe 6th ed., Ch. 21]
• "Peripheral blood mononuclear cells from AgP patients have been reported to exhibit a reduced autologous mixed lymphocyte reaction, as well as a higher than normal response to B-cell mitogens." [Lang-Lindhe 6th ed., Ch. 21]

5D. FcγRII RECEPTOR DYSFUNCTION

• "Poorly functional inherited forms of monocyte FcγRII, the receptor for human immunoglobulin G2 (IgG2) antibodies, have been shown to be disproportionately present in patients with localized aggressive periodontitis." [Carranza 10th ed., Ch. 33]
• "PMNs expressing the R131 allotype of FcγRIIa (i.e., with an Fc receptor containing an arginine instead of a histidine at amino acid 131) show decreased phagocytosis of A. actinomycetemcomitans." [Lang-Lindhe 6th ed., Ch. 21]
• "The H131 allele is the only FCGR2A that recognizes IgG2 efficiently, and optimal IgG2 handling occurs only in the homozygous state for H131. The allelic variant R131 has low binding of IgG2." [Lang-Lindhe 6th ed., Table 21-4]

5E. LOCAL AND SYSTEMIC ANTIBODY RESPONSES

• "B cells and antibody-producing plasma cells represent a significant component of the mononuclear cell-dominated connective tissue lesion." [Lang-Lindhe 6th ed., Ch. 21]
• "Plasma cells have been shown to be predominantly IgG-producing cells, with a lower proportion of IgA-producing cells. Local IgG4-producing cells, in particular, seem to be elevated." [Lang-Lindhe 6th ed., Ch. 21]
• "Crevicular fluid titers of antibodies against AgP-associated microorganisms are frequently higher than in the serum of the same patient, strongly suggesting that substantial fractions of these antibodies are locally produced in the inflammatory infiltrate." [Lang-Lindhe 6th ed., Ch. 21]

• "In LAP the dominant serum antibody isotype IgG2 is specific for surface antigens of A. actinomycetemcomitans, including LPS and at least one major outer membrane protein." [Carranza 10th ed., Ch. 7]
• "High titers and high avidity of A. actinomycetemcomitans-specific IgG2 have been demonstrated in LAP patients, where high antibody titers are thought to be associated with the host's ability to localize attachment loss to a few teeth; conversely, GAP patients are frequently seronegative for A. actinomycetemcomitans or display low titers and avidity." [Lang-Lindhe 6th ed., Ch. 21]
• "Anti-A. actinomycetemcomitans serotype polysaccharide IgG2, therefore, is considered to be protective against widespread AgP (Tew et al. 1996)." [Lang-Lindhe 6th ed., Ch. 21]
• "Patients with elevated antibody response have significantly less loss of attachment." [Carranza 10th ed., Ch. 7]

• "Patients suffering from GAP forms frequently show both low levels of serum antibodies against P. gingivalis and low levels of antibody avidity, indicating a specific inability of some GAP patients to cope effectively with these bacteria." [Lang-Lindhe 6th ed., Ch. 21]

5F. T-CELL ALTERATIONS

• "Subset analysis of local T cells has indicated a depressed T-helper-to-T-suppressor ratio as compared to both healthy gingiva and peripheral blood. These findings have been interpreted to suggest the possibility of altered local immune regulation." [Lang-Lindhe 6th ed., Ch. 21]

5G. HLA ANTIGENS

• "The human leukocyte antigens (HLAs), which regulate immune responses, have been evaluated as candidate markers for aggressive periodontitis. Although the findings with many HLAs have been inconsistent, HLA A9 and B15 antigens are consistently associated with aggressive periodontitis." [Carranza 10th ed., Ch. 33]
• "The risk of disease in subjects with HLA-A9 or B15 is about 1.5 to 3.5 times greater than in those lacking these antigens." [Newman-Carranza 14th ed., Ch. 11]
• "In contrast, the HLA-A2 antigen appears to be less prevalent in patients with aggressive periodontitis than in controls, suggesting that this antigen somehow may be protective." [Newman-Carranza 14th ed., Ch. 11]

5H. AUTOIMMUNITY IN GAP

• "Autoimmunity has a role in generalized aggressive periodontitis, according to Anusaksathien and Dolby, who found host antibodies to collagen, deoxyribonucleic acid (DNA), and IgG. Possible immune mechanisms include an increase in the expression of major histocompatibility complex (MHC) class II molecules, HLA DR4, altered helper or suppressor T-cell function, polyclonal activation of B cells by microbial plaque, and genetic predisposition." [Carranza 10th ed., Ch. 33]

---

6. GENETIC FACTORS

6A. FAMILIAL AGGREGATION

• "Several family studies have indicated that the prevalence of AgP is disproportionately high among certain families, where the percentage of affected siblings may reach 40-50% (Saxen & Nevanlinna 1984; Beaty et al. 1987; Boughman et al. 1992; Marazita et al. 1994)." [Lang-Lindhe 6th ed., Ch. 21]
• "Such a dramatic familial aggregation of cases indicates that genetic factors may be important in susceptibility to AgP." [Lang-Lindhe 6th ed., Ch. 21]
• "Because aggressive periodontitis occurs so rarely, it is not feasible to perform a twin study to confirm the heritability of this condition." [Newman-Carranza 14th ed., Ch. 9]

Table 2: Segregation Analyses of Aggressive Periodontitis (From Newman-Carranza 14th ed., Table 11-2)

• "Despite inconsistent conclusions regarding their mode of inheritance, segregation analyses consistently have supported the role of a major gene in the etiology of the AP diseases. Multifactorial or polygenic models alone cannot adequately account for the patterns of disease observed in families." [Newman-Carranza 14th ed., Ch. 11]

6B. MODE OF INHERITANCE

• "Genetic studies in these families suggest that the pattern of disease transmission is consistent with Mendelian inheritance of a gene of major effect, transmitted through an autosomal dominant mode of inheritance in U.S. populations. It should be noted that most of the segregational studies were conducted in African American populations, and therefore other modes of inheritance may exist in different populations." [Carranza 10th ed., Ch. 33]
• "Segregation analyses have indicated that the likely mode of inheritance is autosomal dominant (Fig. 21-9a). Most of these investigations were carried out in African-American populations; it is therefore possible that other modes of inheritance may exist in different populations." [Lang-Lindhe 6th ed., Ch. 21]

6C. SCHENKEIN'S MODEL - LAP vs. GAP GENETIC DISTINCTION (Examiner Keyword)

• "Schenkein proposed a model of inheritance that distinguishes between the etiologies of localized and generalized aggressive periodontitis. He theorized that AP disease and immunoglobulin G2 (IgG2) responsiveness to bacterial lipopolysaccharide (LPS) segregate independently as dominant and codominant traits, respectively.
  • Subjects with one AP disease allele and two copies of the high-IgG2-response allele would develop only localized disease (LAP).
  • In contrast, subjects who carry the AP disease allele and only one copy of the IgG2 allele would develop more widespread disease (GAP) because their IgG2 response to LPS would be less robust." [Newman-Carranza 14th ed., Ch. 11]

• "(a) Major gene locus: AgP susceptibility gene - Inherited as autosomal dominant trait"
• "(b) Modifying gene locus: IgG2 response allele - Inherited as co-dominant trait. High IgG2 titers limit disease extension. Intermediate and low IgG2 titers are less effective in limiting intermediate disease progression."
• "(c) Independent inheritance of major locus and modifying locus illustrating how LAP and GAP may segregate within the same family." [Lang-Lindhe 6th ed., Ch. 21]

6D. LINKAGE STUDIES

• "Boughman et al. were the first to report linkage between aggressive periodontitis and a specific chromosomal region. They studied an extended family... the putative AP disease gene was localized to the long arm of chromosome 4 (4q11-13) near the gene for DGI." [Newman-Carranza 14th ed., Ch. 11]
• "AP disease has been linked in four families with LAP to a marker on chromosome 1 (1q25) with a LOD score of 3.48." [Newman-Carranza 14th ed., Ch. 11]
• "Another study has linked localized AgP with the q25 region of chromosome 1 in an area close to the cyclooxygenase 2 (COX-2) gene." [Lang-Lindhe 6th ed., Ch. 21]
• "Another has established evidence of linkage with the q13-14 region of chromosome 2 that contains the IL-1 gene complex." [Lang-Lindhe 6th ed., Ch. 21]
• "An investigation utilizing linkage analysis methodology reported linkage of LAP to the vitamin D-binding locus on region q of chromosome 4 in a large family of the Brandywine population. These results, however, were not confirmed in a subsequent study." [Lang-Lindhe 6th ed., Ch. 21]

6E. CANDIDATE GENES FOR AGGRESSIVE PERIODONTITIS

6F. GWAS (GENOME-WIDE ASSOCIATION STUDIES) - RECENT CONCEPT

• "The one GWAS reported for periodontitis revealed a strong association of a glycosyltransferase gene (GLT6D1) with aggressive periodontitis, but there is no clear functional relationship of this gene with periodontal disease pathogenesis." [Newman-Carranza 14th ed., Ch. 9]
• "Most association findings have been drastically underpowered if periodontitis is assumed to be a complex disease... most association reports for chronic and aggressive periodontitis are based on samples of 100 cases or fewer." [Newman-Carranza 14th ed., Ch. 9]

6G. EPIGENETICS - RECENT CONCEPT

• "Epigenetics factors play an important role in chronic inflammatory conditions by allowing microbial persistence to play a role in the infectious mechanism, resulting in pathogen interference with the host genome." [Newman-Carranza 14th ed., Ch. 9]
• "Periodontal pathogens containing lipopolysaccharides can be a cause of epigenetic modifications affecting expression of inflammatory mediators in periodontal tissue, and low-grade chronic inflammation present in periodontal disease has been shown to promote DNA methylation." [Newman-Carranza 14th ed., Ch. 9]
• Histone modifications: "Histone acetylation promotes transcription and is controlled by histone acetyltransferases, which add acetyl groups to lysine residues and histone deacetylases, which remove the acetyl groups from lysine residue." [Newman-Carranza 14th ed., Ch. 9]

---

7. GENETIC AND INHERITED DISORDERS ASSOCIATED WITH AGGRESSIVE PERIODONTITIS

Table 4: Genetic/Inherited Disorders Associated with Aggressive Periodontitis [Newman-Carranza 14th ed., Table 11-1]

---

8. ENVIRONMENTAL FACTORS

8A. CIGARETTE SMOKING

• "The amount and duration of smoking are important variables that can influence the extent of destruction seen in young adults. Patients with generalized aggressive periodontitis who smoke have more affected teeth and more loss of clinical attachment than nonsmoking patients with GAP." [Carranza 10th ed., Ch. 33]
• "Smokers with GAP had more affected teeth and greater mean levels of attachment loss than patients with GAP who did not smoke. Environmental exposure to cigarette smoking, therefore, seems to add significant risk of more severe and prevalent disease to this group of already highly susceptible subjects." [Lang-Lindhe 6th ed., Ch. 21]

• Mechanism: "IgG2 serum levels as well as antibody levels against A. actinomycetemcomitans are significantly depressed in subjects with GAP who smoke. Since these antibodies are considered to represent a protective response against A. actinomycetemcomitans, it is possible that depression of IgG2 in smokers may be associated with the observed increase in disease extent and severity in these subjects." [Lang-Lindhe 6th ed., Ch. 21]
• "Smoking may not have the same impact on attachment levels in younger patients with localized aggressive periodontitis." [Carranza 10th ed., Ch. 33]

8B. RACIAL INFLUENCE

• "A strong racial influence is observed in the United States; the disease is more prevalent among African Americans." [Carranza 10th ed., Ch. 33]
• "Disease allele more frequent in blacks than whites." [Newman-Carranza 14th ed., Ch. 11]
• "The ability to mount high titers of specific antibodies is race dependent and probably protective (Gunsolley et al. 1987, 1988). This has been shown to be under genetic control as a co-dominant trait, independent of the risk for AgP." [Lang-Lindhe 6th ed., Ch. 21]

---

9. CEMENTUM DEFECTS IN PATHOGENESIS

• "Gottlieb (1928) attributed this condition to the inhibition of continuous cementum formation... he termed the disease 'deep cementopathia'." [Carranza 10th ed., Ch. 33]
• "Localization of the lesions could also be due to the defect in cementum formation (hypoplastic/aplastic cementum)." [S. Reddy Essentials, Ch. 26]
• "Lindskog and Blomlöf documented cementum hypoplasia in teeth affected by juvenile periodontitis." [Carranza 10th ed., Ch. 33]

---

10. HOST DEFENSE MECHANISMS IN THE GINGIVAL SULCUS (from Lang-Lindhe 6th ed., Table 21-3)

---

11. PATHOGENESIS SPECIFIC TO LAP - EXPLANATION OF LOCALIZATION

1. After initial colonization of the first permanent teeth to erupt (first molars and incisors), Aa evades host defenses. After this initial attack, adequate immune defenses are stimulated to produce opsonic antibodies (IgG2) to enhance clearance and phagocytosis and neutralize leukotoxic activity - "burnout" phenomenon. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
2. Bacteria antagonistic to A. actinomycetemcomitans may colonize periodontal tissues and inhibit Aa from further colonization. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
3. A. actinomycetemcomitans may lose its leukotoxin-producing ability for unknown reasons. [Carranza 10th ed., Ch. 33; S. Reddy Essentials, Ch. 26]
4. Localization may also be due to defect in cementum formation (hypoplastic/aplastic cementum). [S. Reddy Essentials, Ch. 26]

---

12. PATHOGENESIS SUMMARY FOR LAP AND GAP

Table 7: Summary Comparison of Pathogenesis - LAP vs. GAP vs. Chronic Periodontitis

---

13. DIFFERENT VIEWPOINTS ACROSS REFERENCES

Table 8: Comparison of Different Viewpoints on Etiopathogenesis Across Uploaded References

---

14. PATHOGENESIS OF AGGRESSIVE PERIODONTITIS: SUMMARY FLOWCHART

Flowchart 2: Detailed Pathogenesis of LAP

SUSCEPTIBLE HOST (Genetic predisposition)
PMN dysfunction (75%) + G-protein receptor defect
IgG2 allotype (IgG2 modifying gene)
FcγRIIa R131 allotype (low IgG2 binding)
                |
                ↓
BACTERIAL COLONIZATION
A. actinomycetemcomitans (highly leukotoxic strains)
First permanent teeth to erupt (first molars + incisors)
                |
                ↓
VIRULENCE FACTOR EXPRESSION
Leukotoxin → kills PMNs and macrophages
Chemotaxis inhibitors → prevents PMN migration
LPS/Endotoxin → activates PGE2, IL-1β, TNF-α
Collagenase → degrades collagen
Bacteriocin/Immunosuppressive → inhibits IgG/IgM
                |
                ↓
EVASION OF HOST DEFENSES
Tissue invasion (into connective tissue → bone surface)
Outer membrane vesicles (spread endotoxin)
                |
                ↓
TISSUE DESTRUCTION
MMP-1 (LAP) → collagen degradation
PGE2, IL-1α, IL-1β elevated in GCF → bone resorption
T-helper:suppressor ratio depressed → altered regulation
                |
          ______↓________
          |              |
    IgG2 RESPONSE    LOW IgG2
    (Robust)         (Low/absent)
          |              |
          ↓              ↓
        LAP             GAP
    (Burnout/       (Progressive/
   Self-limiting)  Episodic spread)

---

15. EXAMINER KEYWORDS SUMMARY

Key terms from uploaded references essential for examination answers:

• "Aggregatibacter actinomycetemcomitans" [formerly Actinobacillus actinomycetemcomitans] - recent name change
• "530-bp deletion in the promoter region of the leukotoxin operon" - 10-20x more leukotoxin (Brogan et al.)
• "RTX (Repeats in ToXin) toxins" - pore-forming lytic toxins
• "Highly leukotoxic strains" - over-represented in African-Americans
• "G-protein coupled receptor defect" / "Global membrane receptor defect"
• "GP110 - 40% deficiency"
• "N-formyl-methionyl leucyl phenylalanine (FMLP)"
• "MMP-1 in LAP" vs. "MMP-8 in chronic periodontitis"
• "TIMP-1 elevated in LAP"
• "Hyperresponsive monocyte phenotype" → PGE2 to LPS
• "FcγRIIa - R131 allotype" (arginine) = low IgG2 binding; "H131 allotype" = efficient IgG2 binding
• "IgG2 - protective against widespread AgP" (Tew et al. 1996)
• "Schenkein's model" - AP disease allele (dominant) + IgG2 allele (codominant) → LAP vs. GAP
• "Autosomal dominant" major gene (U.S. populations)
• "HLA-A9 and B15" consistently associated; "HLA-A2" protective
• "HLA DR4" - autoimmunity in GAP
• "Chromosome 1 (1q25)" - LAP linkage (LOD score 3.48)
• "Chromosome 2 (q13-14)" - IL-1 gene complex
• "COX-2 gene region" - chromosome 1 q25 linkage
• "GLT6D1 (glycosyltransferase gene)" - GWAS finding in AgP
• "Burnout phenomenon" - opsonic IgG2 antibodies limit Aa colonization
• "Cementum hypoplasia" (Lindskog & Blomlöf)
• "Polyclonal B-cell activation" - autoimmunity in GAP
• "Epigenetic modifications" / "DNA methylation" promoted by chronic inflammation
• "Transmission of Aa between humans" (parent to child; between spouses)
• "IgG2 depressed in GAP smokers" (Schenkein et al. 1995)
• "Three to four times faster than chronic periodontitis" (rate of bone loss)

---

BIBLIOGRAPHY (from Uploaded References)

1. Newman MG, Carranza FA et al. Carranza's Clinical Periodontology, 10th Edition. Elsevier, 2006-07. Chapters 7 (Pathogenesis of Periodontal Disease), 11 (Genetic Factors Associated with Periodontal Disease), 33 (Aggressive Periodontitis - Novak KF, Novak MJ).
2. Lang NP, Lindhe J (eds.). Clinical Periodontology and Implant Dentistry, 6th Edition. Wiley-Blackwell, 2015. Chapter 21 (Aggressive Periodontitis - Tonetti MS, Mombelli A).
3. Newman MG, Carranza FA et al. Newman and Carranza's Clinical Periodontology and Implantology, 14th Edition. Elsevier, 2023. Chapters 9 (Precision Dentistry: Genetics and Epigenetics), 11 (Genetic Factors Associated with Periodontal Disease).
4. Reddy S. Essentials of Clinical Periodontology and Periodontics. Chapter 26 (Aggressive Periodontitis).
5. Periodontics: Medicine, Surgery and Implants. Chapter 2 (Aggressive Periodontitis).These are your complete postgraduate theory examination notes on "Recent Concepts in Etiopathogenesis of Aggressive Periodontitis", compiled exclusively from your uploaded references. Here is the section index:

---

Section Index